Promethazine and Sumatriptan drug interactions for women aged 50-59 (a phase IV clinical study of FDA data)

< 1 month:

1. Alopecia (absence of hair from areas of the body)
2. Hair colour changes
3. Hair disorder
4. Suicide attempt

1 - 6 months:

1. Alopecia (absence of hair from areas of the body)
2. Hair colour changes
3. Hair disorder

6 - 12 months:

1. Alopecia (absence of hair from areas of the body)
2. Hair colour changes
3. Hair disorder
4. Cystitis (inflammation of the wall of the bladder)
5. Neuropathy peripheral (surface nerve damage)

1 - 2 years:

n/a

2 - 5 years:

1. Alopecia (absence of hair from areas of the body)
2. Hair colour changes
3. Hair disorder

5 - 10 years:

1. Fibromyalgia (a long-term condition which causes pain all over the body)
2. Fluid imbalance (imbalance of fluid in body in intake and fluid lost)
3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
4. Loss of consciousness
5. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
6. Osteoporosis (bones weak and more likely to break)
7. Pain
8. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
9. Pulmonary mass
10. Rib fracture

10+ years:

1. Anxiety
2. Joint swelling
3. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
4. Surgery

not specified:

1. Asthma
2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
3. Drug hypersensitivity
4. Feeling hot
5. Foot fracture
6. Influenza
7. Infusion site haemorrhage (bleeding from infusion site)
8. Injection site warmth
9. Limb discomfort (discomfort in leg)
10. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)